Global Strategy
Responding to the “Healthy China” strategy, focusing on technological innovation to drive the health industry.
Rooted in the Yangtze River Delta, serving all of China.
Against the backdrop of China’s 14th Five-Year Plan, which has incorporated stem cell research into the national key R&D agenda, Sinocell has formulated a nationwide strategy. The company is committed to becoming a model enterprise in cell biology with leading domestic capabilities in fundamental cell research, preparation, storage, and quality control, while advancing technology translation and practical application.
Ningbo Base
(In Production)
Approved as Ningbo’s first regional cell preparation center.
Zhoushan Base
(Completed)
Beijing Base
(In Operation)
Shanghai Base
(Site Selection in Progress)
Shenzhen Base
(Site Selection in Progress)
Chengdu Base
(Site Selection in Progress)
National Health Strategy
We actively respond to the “Healthy China” strategy, focusing on technological innovation to drive the development of the health industry.
With Ningbo as the technology headquarters, the company expands outward with the Pearl River Delta, Yangtze River Delta, Beijing–Tianjin–Hebei, and Chengdu–Chongqing urban clusters as core hubs, forming a multi-node, interconnected layout. This approach gradually strengthens its influence across key regions, including the southeastern coast, North China, Southwest China, and the southern coastal areas.
